sunbet

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Á¬Ã¦ËÑË÷
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
ÈËθ°©×ª»ùÒò¶¯ÎïÄ£×Ó
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Ïû»¯ÏµÍ³Ä£×Ó > ÈËθ°©×ª»ùÒò¶¯ÎïÄ£×Ó

ǰÑÔ

¹úÈËËÀÒòµÄ1/4Êǰ©Ö¢£¬¶ø°©Ö¢ËÀÒòµÄ1/4ÊÇθ°©(gastric cancer)£¬ÔÚÏû»¯ÏµÍ³¶ñÐÔÖ×ÁöéæÃü²¡ÀýÖУ¬Ô¼°ëÊýËÀÓÚθ°©¡£Î¸°©ÆðÔ´ÓÚθ±Ú×î±í²ãµÄð¤Ä¤ÉÏÆ¤Ï¸°û£¬¿É±¬·¢ÓÚθµÄ¸÷¸ö²¿Î»£¨Î¸ñ¼ÓÄÃÅÇø×î¶à¡¢Î¸µ×êÚÃÅÇø´ÎÖ®¡¢Î¸Ì岿ÂÔÉÙ£©£¬¿ÉÇÖռθ±ÚµÄ²î±ðÉî¶ÈºÍ¹ã¶È¡£¶ñÐÔÖ×Áöθ°©ÆðÔ´ÓÚθ±Ú×î±í²ãµÄð¤Ä¤ÉÏÆ¤Ï¸°û£¬¿É±¬·¢ÓÚθµÄ¸÷¸ö²¿Î»£¨Î¸ñ¼ÓÄÃÅÇø×î¶à¡¢Î¸µ×êÚÃÅÇø´ÎÖ®¡¢Î¸Ì岿ÂÔÉÙ£©£¬¿ÉÇÖռθ±ÚµÄ²î±ðÉî¶ÈºÍ¹ã¶È¡£°©Ôî¾ÖÏÞÔÚð¤Ä¤ÄÚ»òð¤Ä¤Ï²ãµÄ³ÆÎªÔçÆÚθ°©£¬ÇÖÕ¼¼¡²ãÒÔÉî»òÓÐ×ªÒÆµ½Î¸ÒÔÍâÇøÓòÕß³ÆÎªÏ£ÍûÆÚθ°©¡£ÈâÑÛ»òθ¾µÊÓ²ìθ°©ÓжàÖÖÐÎ̬£¬Èç±ídzÐÍ¡¢Ö׿éÐÍ¡¢À£ÑñÐÍ¡¢½þÈóÐÍ¡¢À£Ññ°©£¨ÎªÂýÐÔθÀ£Ññ°©±ä£©¡£ÏÔ΢¾µ·Å´óÊӲ착ϸ°ûÓжàÖÖÀàÐÍ£¨×é֯ѧ·ÖÀࣩ£¬ÈçÏÙ°©£¨Õ¼Ô¼90£¥£¬°üÀ¨ÈéÍ·×´ÏÙ°©¡¢¹Ü×´ÏÙ°©¡¢ð¤ÒºÏÙ°©¡¢Ó¡½äϸ°û°©£©¡¢ÏÙÁÛ°©¡¢ÁÛ״ϸ°û°©¡¢Î´·Ö½â°©¡¢Àà°©£¬¸üϸ΢µÄ°©Ï¸°ûÄÚ²¿µÄ·Ö×ӽṹҲÓÐÐí¶à²î±ð£¬Òò´Ë£¬Ëä¶¼³ÆÎªÎ¸°©£¬×ÝÈ»ÈâÑÛºÍÏÔ΢¾µÏÂËù¼ûÀàÐÍÊÇÏàͬµÄ£¬µ«¸öÐÔÈÔÓкܴó²î±ð¡£

Ëæ×Ŷ԰©»ùÒòÑо¿µÄÒ»Ö±ÉîÈ룬ת»ùÒòÊÖÒÕÔÚÖ×ÁöѧÖÐÓ¦ÓÃÒ²Ô½À´Ô½ÆÕ±é¡£×ª»ùÒòθ°©Ä£×ÓÊÇÖ±½Ó½«µ÷¿ØÎ¸°©µÄÏà¹Ø»ùÒòתȾµ½¶¯ÎïÅßÌ¥ÖжøÐγÉÖ×Áö¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó

¡¾ÔìÄ £»úÖÆ¡¿£º

δȪԴÓÚϸ°ûºÍ²¡¶¾Öеİ©»ùÒòºÍÔ­°©»ùÒòÖ²Èë´óÊóµÄÅßÌ¥×éÖ¯ÖУ¬¼Ì¶øÐγÉÖ×ÁöµÄÒªÁì¡£´ËÒªÁìÐγɵÄÖ×ÁöÐÎÌ¬ÌØÕ÷ͬÈË×ÔÈ»±¬·¢µÄÖ×Áö¾ßÓÐÏàËÆÐÔ£¬²¢ÇÒ¾ßÓм«¸ßµÄÌØÒìÐÔ¡£ÆäÖ×ÁöÖ»±¬·¢ÔÚÌØ¶¨µÄ×éÖ¯£¬ÈçתȾÁËÏÙ²¡¶¾12Ela/Elhת»ùÒò´óÊó£¬ÔÚ±âÆ½ÉÏÆ¤ºÍÔ²Öù×´ÉÏÆ¤µÄÍŽáµãÖÜΧÐγÉÁËÀàËÆÓÚÈË×ÔÈ»±¬·¢µÄθ°© £»Óó¤424bpµÄCEAÔö½ø¼ÁSV40T¿¹Ô­×ª»ùÒò¹¹½¨µÄθÏÙ°©Ð¡Êó£¬Ö×ÁöλÓÚÓÄÃŲ¿£¬´«´ú³ÉÁöÂʵִï100£¥¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

θ°©µÄ±¬·¢ºÍÉú³¤ÊÇÒ»¸ö¶àÒòËØ¡¢¶à½×¶ÎµÄÀú³Ì¡£¹Å°åµÄÔìģЧ¹ûÅú×¢£¬ MNNGÍŽáθ°©ÆäËûÏà¹ØÒòËØµÄÍŽṥ»÷£¬ÄÜÏÔ×ÅÌá¸ßÓÕ°©ÂÊ£¬²¢Ëõ¶Ìθ°©µÄÐγÉʱ¼ä¡£µ«Ëæ×Åת»ùÒòθ°©Ä£×ӵķºÆð£¬¿Éͨ¹ýÏÖ´ú·Ö×ÓÉúÎïÊÖÒÕ£¬Î´ÈªÔ´ÓÚϸ°ûºÍ²¡¶¾Öеİ©»ùÒòºÍÔ­°©»ùÒòÖ²Èë´óÊóµÄÅßÌ¥×éÖ¯ÖУ¬¼Ì¶øÐγÉÖ×Áö¡£ÔÚÒ»¶¨Ë®Ñ°³£Ê¹µÃ±âƽÉÏÆ¤ºÍÔ²Öù×´ÉÏÆ¤µÄÍŽáµãÖÜΧÐγÉÁËÀàËÆÓÚÈË×ÔÈ»±¬·¢µÄθ°©¡£ÓÉÓÚÊÇÖ±½Ó½«µ÷¿ØÎ¸°© µÄÏà¹Ø»ùÒòתȾµ½¶¯ÎïÅßÌ¥ÖжøÐγÉÐÎÌ¬ÌØÕ÷ÓëÈËθ°©ÏàÀàËÆµÄÖ×ÁöÁËÒò´ËÊÇÒ»ÖÖ×îΪÀíÏëµÄθ°©Ä£×Ó£¬½«³ÉΪδÀ´Ñо¿Î¸°©µÄÖ÷Ҫģ×Ó¡£

 

²Î¿¼ÎÄÏ×£º

1.ÍõÄþ£¬Íõ±ó£¬ÍõÑŽܣ®Avastin¶Ôθ°©ÂãÊóÔ­Î»ÒÆÖ²Ä£×ÓѪ¹ÜÌìÉúµÄÓ°Ïì°©Ö¢£¬2006, 25 (9):1076-1081

2.ËïÓÀÇ¿£¬ÍõÇ¿£¬Ö£¹ú¾²£¬µÈ. ÂÞ·ÇÎô²¼¶ÔÂãÊóÈËθ°©Ô­Î»ÝªÖ²Áö×éÖ¯ÖÐѪ¹ÜÄÚÆ¤Éú³¤Òò×ÓºÍÓÕµ¼ÐÍÒ»Ñõ»¯µªºÏø±í´ïµÄÓ°Ï죮µÚÈý¾üÒ½´óѧѧ±¨£¬2007,29(10): 929-931

3.Bilici M, Cayir K, Tekin SB, et al. Effect of mirtazapine on MNNG-induced gastric adenocarcinoma in rats. Asian Pac J CancerPrev,2012, 13(10):4897-4900

4.Jantscheff P, Ziroli V, Esser N, el al. Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model. Clin Exp Metastasis, 2009, 26 (8):981-992

sunbet(ÖйúÇø)¹Ù·½ÍøÕ¾Èë¿Ú
Ä£×ÓĿ¼
Ä¿½ñλÖãºÊ×Ò³ > ÈËÀ༲²¡¶¯ÎïÄ£×ÓĿ¼ > Ïû»¯ÏµÍ³Ä£×Ó > ÈËθ°©×ª»ùÒò¶¯ÎïÄ£×Ó
ÈËθ°©×ª»ùÒò¶¯ÎïÄ£×Ó

ǰÑÔ

¹úÈËËÀÒòµÄ1/4Êǰ©Ö¢£¬¶ø°©Ö¢ËÀÒòµÄ1/4ÊÇθ°©(gastric cancer)£¬ÔÚÏû»¯ÏµÍ³¶ñÐÔÖ×ÁöéæÃü²¡ÀýÖУ¬Ô¼°ëÊýËÀÓÚθ°©¡£Î¸°©ÆðÔ´ÓÚθ±Ú×î±í²ãµÄð¤Ä¤ÉÏÆ¤Ï¸°û£¬¿É±¬·¢ÓÚθµÄ¸÷¸ö²¿Î»£¨Î¸ñ¼ÓÄÃÅÇø×î¶à¡¢Î¸µ×êÚÃÅÇø´ÎÖ®¡¢Î¸Ì岿ÂÔÉÙ£©£¬¿ÉÇÖռθ±ÚµÄ²î±ðÉî¶ÈºÍ¹ã¶È¡£¶ñÐÔÖ×Áöθ°©ÆðÔ´ÓÚθ±Ú×î±í²ãµÄð¤Ä¤ÉÏÆ¤Ï¸°û£¬¿É±¬·¢ÓÚθµÄ¸÷¸ö²¿Î»£¨Î¸ñ¼ÓÄÃÅÇø×î¶à¡¢Î¸µ×êÚÃÅÇø´ÎÖ®¡¢Î¸Ì岿ÂÔÉÙ£©£¬¿ÉÇÖռθ±ÚµÄ²î±ðÉî¶ÈºÍ¹ã¶È¡£°©Ôî¾ÖÏÞÔÚð¤Ä¤ÄÚ»òð¤Ä¤Ï²ãµÄ³ÆÎªÔçÆÚθ°©£¬ÇÖÕ¼¼¡²ãÒÔÉî»òÓÐ×ªÒÆµ½Î¸ÒÔÍâÇøÓòÕß³ÆÎªÏ£ÍûÆÚθ°©¡£ÈâÑÛ»òθ¾µÊÓ²ìθ°©ÓжàÖÖÐÎ̬£¬Èç±ídzÐÍ¡¢Ö׿éÐÍ¡¢À£ÑñÐÍ¡¢½þÈóÐÍ¡¢À£Ññ°©£¨ÎªÂýÐÔθÀ£Ññ°©±ä£©¡£ÏÔ΢¾µ·Å´óÊӲ착ϸ°ûÓжàÖÖÀàÐÍ£¨×é֯ѧ·ÖÀࣩ£¬ÈçÏÙ°©£¨Õ¼Ô¼90£¥£¬°üÀ¨ÈéÍ·×´ÏÙ°©¡¢¹Ü×´ÏÙ°©¡¢ð¤ÒºÏÙ°©¡¢Ó¡½äϸ°û°©£©¡¢ÏÙÁÛ°©¡¢ÁÛ״ϸ°û°©¡¢Î´·Ö½â°©¡¢Àà°©£¬¸üϸ΢µÄ°©Ï¸°ûÄÚ²¿µÄ·Ö×ӽṹҲÓÐÐí¶à²î±ð£¬Òò´Ë£¬Ëä¶¼³ÆÎªÎ¸°©£¬×ÝÈ»ÈâÑÛºÍÏÔ΢¾µÏÂËù¼ûÀàÐÍÊÇÏàͬµÄ£¬µ«¸öÐÔÈÔÓкܴó²î±ð¡£

Ëæ×Ŷ԰©»ùÒòÑо¿µÄÒ»Ö±ÉîÈ룬ת»ùÒòÊÖÒÕÔÚÖ×ÁöѧÖÐÓ¦ÓÃÒ²Ô½À´Ô½ÆÕ±é¡£×ª»ùÒòθ°©Ä£×ÓÊÇÖ±½Ó½«µ÷¿ØÎ¸°©µÄÏà¹Ø»ùÒòתȾµ½¶¯ÎïÅßÌ¥ÖжøÐγÉÖ×Áö¡£

²¿·ÖÔìÄ£ÒªÁì

ʹÓö¯Î´óÊó

¡¾ÔìÄ £»úÖÆ¡¿£º

δȪԴÓÚϸ°ûºÍ²¡¶¾Öеİ©»ùÒòºÍÔ­°©»ùÒòÖ²Èë´óÊóµÄÅßÌ¥×éÖ¯ÖУ¬¼Ì¶øÐγÉÖ×ÁöµÄÒªÁì¡£´ËÒªÁìÐγɵÄÖ×ÁöÐÎÌ¬ÌØÕ÷ͬÈË×ÔÈ»±¬·¢µÄÖ×Áö¾ßÓÐÏàËÆÐÔ£¬²¢ÇÒ¾ßÓм«¸ßµÄÌØÒìÐÔ¡£ÆäÖ×ÁöÖ»±¬·¢ÔÚÌØ¶¨µÄ×éÖ¯£¬ÈçתȾÁËÏÙ²¡¶¾12Ela/Elhת»ùÒò´óÊó£¬ÔÚ±âÆ½ÉÏÆ¤ºÍÔ²Öù×´ÉÏÆ¤µÄÍŽáµãÖÜΧÐγÉÁËÀàËÆÓÚÈË×ÔÈ»±¬·¢µÄθ°© £»Óó¤424bpµÄCEAÔö½ø¼ÁSV40T¿¹Ô­×ª»ùÒò¹¹½¨µÄθÏÙ°©Ð¡Êó£¬Ö×ÁöλÓÚÓÄÃŲ¿£¬´«´ú³ÉÁöÂʵִï100£¥¡£

¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º

θ°©µÄ±¬·¢ºÍÉú³¤ÊÇÒ»¸ö¶àÒòËØ¡¢¶à½×¶ÎµÄÀú³Ì¡£¹Å°åµÄÔìģЧ¹ûÅú×¢£¬ MNNGÍŽáθ°©ÆäËûÏà¹ØÒòËØµÄÍŽṥ»÷£¬ÄÜÏÔ×ÅÌá¸ßÓÕ°©ÂÊ£¬²¢Ëõ¶Ìθ°©µÄÐγÉʱ¼ä¡£µ«Ëæ×Åת»ùÒòθ°©Ä£×ӵķºÆð£¬¿Éͨ¹ýÏÖ´ú·Ö×ÓÉúÎïÊÖÒÕ£¬Î´ÈªÔ´ÓÚϸ°ûºÍ²¡¶¾Öеİ©»ùÒòºÍÔ­°©»ùÒòÖ²Èë´óÊóµÄÅßÌ¥×éÖ¯ÖУ¬¼Ì¶øÐγÉÖ×Áö¡£ÔÚÒ»¶¨Ë®Ñ°³£Ê¹µÃ±âƽÉÏÆ¤ºÍÔ²Öù×´ÉÏÆ¤µÄÍŽáµãÖÜΧÐγÉÁËÀàËÆÓÚÈË×ÔÈ»±¬·¢µÄθ°©¡£ÓÉÓÚÊÇÖ±½Ó½«µ÷¿ØÎ¸°© µÄÏà¹Ø»ùÒòתȾµ½¶¯ÎïÅßÌ¥ÖжøÐγÉÐÎÌ¬ÌØÕ÷ÓëÈËθ°©ÏàÀàËÆµÄÖ×ÁöÁËÒò´ËÊÇÒ»ÖÖ×îΪÀíÏëµÄθ°©Ä£×Ó£¬½«³ÉΪδÀ´Ñо¿Î¸°©µÄÖ÷Ҫģ×Ó¡£

 

²Î¿¼ÎÄÏ×£º

1.ÍõÄþ£¬Íõ±ó£¬ÍõÑŽܣ®Avastin¶Ôθ°©ÂãÊóÔ­Î»ÒÆÖ²Ä£×ÓѪ¹ÜÌìÉúµÄÓ°Ïì°©Ö¢£¬2006, 25 (9):1076-1081

2.ËïÓÀÇ¿£¬ÍõÇ¿£¬Ö£¹ú¾²£¬µÈ. ÂÞ·ÇÎô²¼¶ÔÂãÊóÈËθ°©Ô­Î»ÝªÖ²Áö×éÖ¯ÖÐѪ¹ÜÄÚÆ¤Éú³¤Òò×ÓºÍÓÕµ¼ÐÍÒ»Ñõ»¯µªºÏø±í´ïµÄÓ°Ï죮µÚÈý¾üÒ½´óѧѧ±¨£¬2007,29(10): 929-931

3.Bilici M, Cayir K, Tekin SB, et al. Effect of mirtazapine on MNNG-induced gastric adenocarcinoma in rats. Asian Pac J CancerPrev,2012, 13(10):4897-4900

4.Jantscheff P, Ziroli V, Esser N, el al. Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model. Clin Exp Metastasis, 2009, 26 (8):981-992

¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿